世界の院内感染症検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hospital Acquired Disease Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2903 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、院内感染症検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器・試薬、消耗品）、用途別市場規模（疾病検査、薬剤耐性検査）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・院内感染症検査の市場動向 ・企業の競争状況、市場シェア ・院内感染症検査の種類別市場規模（機器・試薬、消耗品） ・院内感染症検査の用途別市場規模（疾病検査、薬剤耐性検査） ・院内感染症検査の北米市場規模2016-2027（アメリカ、カナダ） ・院内感染症検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・院内感染症検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・院内感染症検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・院内感染症検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Life technologies、Diatherix laboratories、Qiagen GmbH、Meridian Biosciences、Nordion、Roche、Cantel Medical Corporation、Cepheid） ・結論

Hosptial infection is categorized based on infection types into the following segments: blood stream infection (BSI) testing, urinary tract infection (UTI) testing, methicilin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing & others infections such as cardio vascular infection, gastrointestinal infections & respiratory infections.
One of the key factors driving industry growth is the rising geriatric population base. Advancing age of the geriatric population makes them more vulnerable and prone to diseases, thus increasing the demand for diagnosis. Other aspects supporting industry growth are growing demand of HAI diagnostics from middle and low-income countries such as India and Brazil, development of technologically advanced diagnostic products, rising awareness among healthcare workers, and initiatives taken by governments to counter the prevalence of HAIs. However, decreasing prevalence of nosocomial infections in the developed countries owing to improved healthcare infrastructure and rising awareness are expected to restrict industry growth.

Market Analysis and Insights: Global Hospital Acquired Disease Testing Market
The global Hospital Acquired Disease Testing market size is projected to reach US$ 969.2 million by 2026, from US$ 453.2 million in 2019, at a CAGR of 11.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital Acquired Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital Acquired Disease Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital Acquired Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital Acquired Disease Testing market.

Global Hospital Acquired Disease Testing Scope and Market Size
Hospital Acquired Disease Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Instrument and Reagents
Consumables

Segment by Application
Disease Testing
Drug-Resistance Testing

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Life technologies
Diatherix laboratories
Qiagen GmbH
Meridian Biosciences
Nordion
Roche
Cantel Medical Corporation
Cepheid

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Acquired Disease Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instrument and Reagents
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Hospital Acquired Disease Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Disease Testing
1.3.3 Drug-Resistance Testing
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hospital Acquired Disease Testing Market Perspective (2016-2027)
2.2 Hospital Acquired Disease Testing Growth Trends by Regions
2.2.1 Hospital Acquired Disease Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hospital Acquired Disease Testing Historic Market Share by Regions (2016-2021)
2.2.3 Hospital Acquired Disease Testing Forecasted Market Size by Regions (2022-2027)
2.3 Hospital Acquired Disease Testing Industry Dynamic
2.3.1 Hospital Acquired Disease Testing Market Trends
2.3.2 Hospital Acquired Disease Testing Market Drivers
2.3.3 Hospital Acquired Disease Testing Market Challenges
2.3.4 Hospital Acquired Disease Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Disease Testing Players by Revenue
3.1.1 Global Top Hospital Acquired Disease Testing Players by Revenue (2016-2021)
3.1.2 Global Hospital Acquired Disease Testing Revenue Market Share by Players (2016-2021)
3.2 Global Hospital Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hospital Acquired Disease Testing Revenue
3.4 Global Hospital Acquired Disease Testing Market Concentration Ratio
3.4.1 Global Hospital Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Disease Testing Revenue in 2020
3.5 Hospital Acquired Disease Testing Key Players Head office and Area Served
3.6 Key Players Hospital Acquired Disease Testing Product Solution and Service
3.7 Date of Enter into Hospital Acquired Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital Acquired Disease Testing Breakdown Data by Type
4.1 Global Hospital Acquired Disease Testing Historic Market Size by Type (2016-2021)
4.2 Global Hospital Acquired Disease Testing Forecasted Market Size by Type (2022-2027)

5 Hospital Acquired Disease Testing Breakdown Data by Application
5.1 Global Hospital Acquired Disease Testing Historic Market Size by Application (2016-2021)
5.2 Global Hospital Acquired Disease Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hospital Acquired Disease Testing Market Size (2016-2027)
6.2 North America Hospital Acquired Disease Testing Market Size by Type
6.2.1 North America Hospital Acquired Disease Testing Market Size by Type (2016-2021)
6.2.2 North America Hospital Acquired Disease Testing Market Size by Type (2022-2027)
6.2.3 North America Hospital Acquired Disease Testing Market Size by Type (2016-2027)
6.3 North America Hospital Acquired Disease Testing Market Size by Application
6.3.1 North America Hospital Acquired Disease Testing Market Size by Application (2016-2021)
6.3.2 North America Hospital Acquired Disease Testing Market Size by Application (2022-2027)
6.3.3 North America Hospital Acquired Disease Testing Market Size by Application (2016-2027)
6.4 North America Hospital Acquired Disease Testing Market Size by Country
6.4.1 North America Hospital Acquired Disease Testing Market Size by Country (2016-2021)
6.4.2 North America Hospital Acquired Disease Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hospital Acquired Disease Testing Market Size (2016-2027)
7.2 Europe Hospital Acquired Disease Testing Market Size by Type
7.2.1 Europe Hospital Acquired Disease Testing Market Size by Type (2016-2021)
7.2.2 Europe Hospital Acquired Disease Testing Market Size by Type (2022-2027)
7.2.3 Europe Hospital Acquired Disease Testing Market Size by Type (2016-2027)
7.3 Europe Hospital Acquired Disease Testing Market Size by Application
7.3.1 Europe Hospital Acquired Disease Testing Market Size by Application (2016-2021)
7.3.2 Europe Hospital Acquired Disease Testing Market Size by Application (2022-2027)
7.3.3 Europe Hospital Acquired Disease Testing Market Size by Application (2016-2027)
7.4 Europe Hospital Acquired Disease Testing Market Size by Country
7.4.1 Europe Hospital Acquired Disease Testing Market Size by Country (2016-2021)
7.4.2 Europe Hospital Acquired Disease Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Disease Testing Market Size (2016-2027)
8.2 Asia-Pacific Hospital Acquired Disease Testing Market Size by Type
8.2.1 Asia-Pacific Hospital Acquired Disease Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hospital Acquired Disease Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hospital Acquired Disease Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Hospital Acquired Disease Testing Market Size by Application
8.3.1 Asia-Pacific Hospital Acquired Disease Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hospital Acquired Disease Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hospital Acquired Disease Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Hospital Acquired Disease Testing Market Size by Region
8.4.1 Asia-Pacific Hospital Acquired Disease Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hospital Acquired Disease Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hospital Acquired Disease Testing Market Size (2016-2027)
9.2 Latin America Hospital Acquired Disease Testing Market Size by Type
9.2.1 Latin America Hospital Acquired Disease Testing Market Size by Type (2016-2021)
9.2.2 Latin America Hospital Acquired Disease Testing Market Size by Type (2022-2027)
9.2.3 Latin America Hospital Acquired Disease Testing Market Size by Type (2016-2027)
9.3 Latin America Hospital Acquired Disease Testing Market Size by Application
9.3.1 Latin America Hospital Acquired Disease Testing Market Size by Application (2016-2021)
9.3.2 Latin America Hospital Acquired Disease Testing Market Size by Application (2022-2027)
9.3.3 Latin America Hospital Acquired Disease Testing Market Size by Application (2016-2027)
9.4 Latin America Hospital Acquired Disease Testing Market Size by Country
9.4.1 Latin America Hospital Acquired Disease Testing Market Size by Country (2016-2021)
9.4.2 Latin America Hospital Acquired Disease Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Disease Testing Market Size (2016-2027)
10.2 Middle East & Africa Hospital Acquired Disease Testing Market Size by Type
10.2.1 Middle East & Africa Hospital Acquired Disease Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hospital Acquired Disease Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hospital Acquired Disease Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Hospital Acquired Disease Testing Market Size by Application
10.3.1 Middle East & Africa Hospital Acquired Disease Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hospital Acquired Disease Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hospital Acquired Disease Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Hospital Acquired Disease Testing Market Size by Country
10.4.1 Middle East & Africa Hospital Acquired Disease Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hospital Acquired Disease Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Life technologies
11.1.1 Life technologies Company Details
11.1.2 Life technologies Business Overview
11.1.3 Life technologies Hospital Acquired Disease Testing Introduction
11.1.4 Life technologies Revenue in Hospital Acquired Disease Testing Business (2016-2021)
11.1.5 Life technologies Recent Development
11.2 Diatherix laboratories
11.2.1 Diatherix laboratories Company Details
11.2.2 Diatherix laboratories Business Overview
11.2.3 Diatherix laboratories Hospital Acquired Disease Testing Introduction
11.2.4 Diatherix laboratories Revenue in Hospital Acquired Disease Testing Business (2016-2021)
11.2.5 Diatherix laboratories Recent Development
11.3 Qiagen GmbH
11.3.1 Qiagen GmbH Company Details
11.3.2 Qiagen GmbH Business Overview
11.3.3 Qiagen GmbH Hospital Acquired Disease Testing Introduction
11.3.4 Qiagen GmbH Revenue in Hospital Acquired Disease Testing Business (2016-2021)
11.3.5 Qiagen GmbH Recent Development
11.4 Meridian Biosciences
11.4.1 Meridian Biosciences Company Details
11.4.2 Meridian Biosciences Business Overview
11.4.3 Meridian Biosciences Hospital Acquired Disease Testing Introduction
11.4.4 Meridian Biosciences Revenue in Hospital Acquired Disease Testing Business (2016-2021)
11.4.5 Meridian Biosciences Recent Development
11.5 Nordion
11.5.1 Nordion Company Details
11.5.2 Nordion Business Overview
11.5.3 Nordion Hospital Acquired Disease Testing Introduction
11.5.4 Nordion Revenue in Hospital Acquired Disease Testing Business (2016-2021)
11.5.5 Nordion Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Hospital Acquired Disease Testing Introduction
11.6.4 Roche Revenue in Hospital Acquired Disease Testing Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Cantel Medical Corporation
11.7.1 Cantel Medical Corporation Company Details
11.7.2 Cantel Medical Corporation Business Overview
11.7.3 Cantel Medical Corporation Hospital Acquired Disease Testing Introduction
11.7.4 Cantel Medical Corporation Revenue in Hospital Acquired Disease Testing Business (2016-2021)
11.7.5 Cantel Medical Corporation Recent Development
11.8 Cepheid
11.8.1 Cepheid Company Details
11.8.2 Cepheid Business Overview
11.8.3 Cepheid Hospital Acquired Disease Testing Introduction
11.8.4 Cepheid Revenue in Hospital Acquired Disease Testing Business (2016-2021)
11.8.5 Cepheid Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hospital Acquired Disease Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instrument and Reagents
Table 3. Key Players of Consumables
Table 4. Global Hospital Acquired Disease Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hospital Acquired Disease Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hospital Acquired Disease Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hospital Acquired Disease Testing Market Share by Regions (2016-2021)
Table 8. Global Hospital Acquired Disease Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hospital Acquired Disease Testing Market Share by Regions (2022-2027)
Table 10. Hospital Acquired Disease Testing Market Trends
Table 11. Hospital Acquired Disease Testing Market Drivers
Table 12. Hospital Acquired Disease Testing Market Challenges
Table 13. Hospital Acquired Disease Testing Market Restraints
Table 14. Global Hospital Acquired Disease Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hospital Acquired Disease Testing Market Share by Players (2016-2021)
Table 16. Global Top Hospital Acquired Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Disease Testing as of 2020)
Table 17. Ranking of Global Top Hospital Acquired Disease Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hospital Acquired Disease Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hospital Acquired Disease Testing Product Solution and Service
Table 21. Date of Enter into Hospital Acquired Disease Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hospital Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hospital Acquired Disease Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Hospital Acquired Disease Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hospital Acquired Disease Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hospital Acquired Disease Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hospital Acquired Disease Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Hospital Acquired Disease Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hospital Acquired Disease Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hospital Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hospital Acquired Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hospital Acquired Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hospital Acquired Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hospital Acquired Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hospital Acquired Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hospital Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hospital Acquired Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hospital Acquired Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hospital Acquired Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hospital Acquired Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hospital Acquired Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hospital Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hospital Acquired Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hospital Acquired Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hospital Acquired Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hospital Acquired Disease Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hospital Acquired Disease Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hospital Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hospital Acquired Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hospital Acquired Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hospital Acquired Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hospital Acquired Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hospital Acquired Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hospital Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hospital Acquired Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hospital Acquired Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hospital Acquired Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hospital Acquired Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hospital Acquired Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Life technologies Company Details
Table 62. Life technologies Business Overview
Table 63. Life technologies Hospital Acquired Disease Testing Product
Table 64. Life technologies Revenue in Hospital Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 65. Life technologies Recent Development
Table 66. Diatherix laboratories Company Details
Table 67. Diatherix laboratories Business Overview
Table 68. Diatherix laboratories Hospital Acquired Disease Testing Product
Table 69. Diatherix laboratories Revenue in Hospital Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 70. Diatherix laboratories Recent Development
Table 71. Qiagen GmbH Company Details
Table 72. Qiagen GmbH Business Overview
Table 73. Qiagen GmbH Hospital Acquired Disease Testing Product
Table 74. Qiagen GmbH Revenue in Hospital Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 75. Qiagen GmbH Recent Development
Table 76. Meridian Biosciences Company Details
Table 77. Meridian Biosciences Business Overview
Table 78. Meridian Biosciences Hospital Acquired Disease Testing Product
Table 79. Meridian Biosciences Revenue in Hospital Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 80. Meridian Biosciences Recent Development
Table 81. Nordion Company Details
Table 82. Nordion Business Overview
Table 83. Nordion Hospital Acquired Disease Testing Product
Table 84. Nordion Revenue in Hospital Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 85. Nordion Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Hospital Acquired Disease Testing Product
Table 89. Roche Revenue in Hospital Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Cantel Medical Corporation Company Details
Table 92. Cantel Medical Corporation Business Overview
Table 93. Cantel Medical Corporation Hospital Acquired Disease Testing Product
Table 94. Cantel Medical Corporation Revenue in Hospital Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 95. Cantel Medical Corporation Recent Development
Table 96. Cepheid Company Details
Table 97. Cepheid Business Overview
Table 98. Cepheid Revenue in Hospital Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 99. Cepheid Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Acquired Disease Testing Market Share by Type: 2020 VS 2027
Figure 2. Instrument and Reagents Features
Figure 3. Consumables Features
Figure 4. Global Hospital Acquired Disease Testing Market Share by Application: 2020 VS 2027
Figure 5. Disease Testing Case Studies
Figure 6. Drug-Resistance Testing Case Studies
Figure 7. Hospital Acquired Disease Testing Report Years Considered
Figure 8. Global Hospital Acquired Disease Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Hospital Acquired Disease Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hospital Acquired Disease Testing Market Share by Regions: 2020 VS 2027
Figure 11. Global Hospital Acquired Disease Testing Market Share by Regions (2022-2027)
Figure 12. Global Hospital Acquired Disease Testing Market Share by Players in 2020
Figure 13. Global Top Hospital Acquired Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Disease Testing as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Hospital Acquired Disease Testing Revenue in 2020
Figure 15. Global Hospital Acquired Disease Testing Revenue Market Share by Type (2016-2021)
Figure 16. Global Hospital Acquired Disease Testing Revenue Market Share by Type (2022-2027)
Figure 17. North America Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Hospital Acquired Disease Testing Market Share by Type (2016-2027)
Figure 19. North America Hospital Acquired Disease Testing Market Share by Application (2016-2027)
Figure 20. North America Hospital Acquired Disease Testing Market Share by Country (2016-2027)
Figure 21. United States Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hospital Acquired Disease Testing Market Share by Type (2016-2027)
Figure 25. Europe Hospital Acquired Disease Testing Market Share by Application (2016-2027)
Figure 26. Europe Hospital Acquired Disease Testing Market Share by Country (2016-2027)
Figure 27. Germany Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hospital Acquired Disease Testing Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Hospital Acquired Disease Testing Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Hospital Acquired Disease Testing Market Share by Region (2016-2027)
Figure 37. China Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hospital Acquired Disease Testing Market Share by Type (2016-2027)
Figure 45. Latin America Hospital Acquired Disease Testing Market Share by Application (2016-2027)
Figure 46. Latin America Hospital Acquired Disease Testing Market Share by Country (2016-2027)
Figure 47. Mexico Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hospital Acquired Disease Testing Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Hospital Acquired Disease Testing Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Hospital Acquired Disease Testing Market Share by Country (2016-2027)
Figure 53. Turkey Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Hospital Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Life technologies Revenue Growth Rate in Hospital Acquired Disease Testing Business (2016-2021)
Figure 57. Diatherix laboratories Revenue Growth Rate in Hospital Acquired Disease Testing Business (2016-2021)
Figure 58. Qiagen GmbH Revenue Growth Rate in Hospital Acquired Disease Testing Business (2016-2021)
Figure 59. Meridian Biosciences Revenue Growth Rate in Hospital Acquired Disease Testing Business (2016-2021)
Figure 60. Nordion Revenue Growth Rate in Hospital Acquired Disease Testing Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Hospital Acquired Disease Testing Business (2016-2021)
Figure 62. Cantel Medical Corporation Revenue Growth Rate in Hospital Acquired Disease Testing Business (2016-2021)
Figure 63. Cepheid Revenue Growth Rate in Hospital Acquired Disease Testing Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---